Vanilla Treats Crackers recall

Recalled by Rovira Biscuit Corporation · Ponce, PR, United States

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Undeclared colors FD&C Yellow #6, and FD&C Red 40

A label that does not match the product can hide an ingredient someone must avoid, or show a wrong use-by date. All labeling errors recalls.

What was recalled

Vanilla Treats Crackers, Rovira, Net Wt. 31 oz (878.83 g) cans, 6/31oz cans per case. Mini Vanilla Treats, Rovira, 12 to go packs (0.8oz (22.7g) each), Net Wt 9.6 oz (272g), 6/9.6oz boxes per case. UPC072981005374

Quantity: 71,492 units

Food: Chips & snacks

Lot codes, dates and UPCs

A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.

Lot numbers: 6/31 oz cans 11625 12725 21325 30325 40725 42926 50625 52625 60925 62425 70125 71525 80425 91624 91825 92925 103025 111124 111325 112524 112525 121624 Lot number: 6/9.6oz 11625 12725 21325 30325 40725 42926 50625 52625 60925 62425 70125 71525 80425 91624 91825 92925 103025 111124 111325 112524 112525 121624

Where it was sold

Georgia Illinois Massachusetts Maryland Puerto Rico Texas

FDA's distribution note: GA, TX, MA, IL, MD, USVI and Puerto Rico. Foreign Panama and BVI

Check the codes, then return or discard. Class II means eating it may cause temporary or reversible health problems. If your package matches the recalled codes, do not eat it - return it to the store or throw it away. FDA lists this recall as terminated: the company has finished removing the product, so it should no longer be on shelves - but it can still be in a freezer or pantry.

Recalling firm: Rovira Biscuit Corporation
Initiated by: Voluntary: Firm initiated
Recall initiated: Dec 17, 2025
In FDA report of: Jan 14, 2026
Terminated: Apr 7, 2026
FDA recall number: H-0361-2026 · event 98174
Official record: FDA enforcement report search

Also recalled with it (5 more products)

FDA files each product of one recall action separately; these share the same FDA event.

Class II · Moderate risk Terminated Labeling Dec 17, 2025